ReCode is developing therapeutics for genetically defined diseases with no existing treatment options including cystic fibrosis and primary ciliary dyskinesia.
ReCode Therapeutics is a US-based, clinical-stage genetic medicines company is developing therapeutics for genetically.
read more
Erytech Pharma is a clinical-stage biopharmaceutical company best known for its proprietary ERYCAPS® red cell encapsulation platform
Erytech Pharma SA is a clinical-stage biopharmaceutical company based in Lyon, France, best known for its proprietary.
read more
DemeRx is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of addiction.
DemeRx is a US-based clinical stage pharmaceutical development company advancing drug candidates as therapies for.
read more
Cleothena Enterprises Pty Ltd. is a forward-thinking biotechnology company focused on advancing innovative therapeutic solutions.
Cleothena Enterprises Pty Ltd. is a forward-thinking biotechnology company focused on advancing innovative therapeutic.
read more
BSH is the UK’s largest haematology organisation, promoting excellence within the field and supporting professional development.
The British Society for Haematology (BSH), the UK’s largest haematology organisation, promotes excellence within the.
read more
Cardionetics is an innovative hardware and software solutions company specialising in providing intelligent systems for diagnostic, monitoring, and screening purposes.
Cardionetics is an innovative hardware and software solutions company specialising in providing intelligent systems for.
read more
Recardio Inc is a life science company that focuses on drug-based regenerative therapeutic modalities for treatments of cardiovascular diseases.
Recardio is a life science company that focuses on drug-based regenerative therapeutic modalities for treatments of.
read more
Surface Logix is a drug development company using biophysical chemistry to create new small molecule drugs.
Surface Logix is a drug development company which uses its expertise in biophysical chemistry to create new small.
read more
A specialist pharmaceutical company dedicated to HIV medicines and research with an extensive portfolio of prescription medicines.
A specialist pharmaceutical company dedicated to HIV medicines and research with an extensive portfolio of prescription.
read more
A specialist respiratory biotech company whose primary focus is developing our investigative inhaled IFN-β for the treatment of severe viral lung infections.
Synairgen is a UK-based biopharmaceutical company focused on developing innovative treatments for respiratory diseases,.
read more
Orchard focuses on key competencies internally, while engaging with bespoke service providers to deliver important aspects of their business.
Following the acquisition of Strimvelis and associated gene therapy assets by Orchard Therapeutics, our contributions.
read more
Nabriva Therapeutics is committed to developing new antibiotics to treat infectious diseases.
Nabriva Therapeutics was incorporated as a spin-off from Sandoz GmbH Antibiotics Research Institute (ABRI) in Vienna..
read more
